1.Antibiotic sensitivity of Propionibacterium acnes isolated from patients with acne vulgaris in Kuala Lumpur Hospital,Malaysia
Dr Tang Jyh Jong ; Agnes H ; Chan LC ; Roshidah B
Malaysian Journal of Dermatology 2011;27(-):18-18
Background
Antibiotic therapy directed against Propionibacterium acnes has been a mainstay of treatment in acne vulgaris for more
than 40 years. Prolonged antibiotic usage has been associated with emergence of antibiotic-resistant P. acnes and is linked
to treatment failure. Little work has been done in Malaysia on drug resistance in P. acnes and there is no surveillance data
on this aspect to guide the clinical decision.
Objective
This study aims to evaluate antibiotic sensitivity of P. acnes isolated from patients with acne vulgaris in Kuala Lumpur
Hospital, Malaysia.
Methods
This is a non interventional, single centered, cross-sectional hospital-based survey of antibiotic sensitivity of P. acnes
isolated from patients with acne vulgaris in Kuala Lumpur Hospital from January 2010 to June 2010.
Results
A total of 100 patients were recruited in our study. P. acnes was isolated in 53% of patients and 11% had gram negative
organism. Antibiotic resistant P. acnes was found in 15.1% of positive isolates. Clindamycin resistance was most common
(15.1%) followed by erythromycin (7.5%), doxycycline (5.7%), tetracycline (1.9%) and minocycline (0%). Isolates of
antibiotic resistant P. acnes was significantly higher in patients treated with antibiotics within the last 6 months (29%)
as compared with non antibiotic treated patients (0%) (p<0.05). The mean duration of prior antibiotic treatment was
significantly longer in the group of antibiotic resistant P. acnes as compared with antibiotic sensitive P. acnes (17.13 weeks
vs 5.74 weeks, p<0.05).
Conclusion
Antibiotic resistant P. acnes is present locally with clindamycin and erythromycin conferring the highest resistance. Longer
duration of antibiotic treatment predisposes to antibiotic resistant P. acnes and may also induce emergence of gram
negative organisms. Strategies to reduce antibiotic resistance should be emphasized when prescribing antibiotic for acne
vulgaris in order to achieve optimal therapeutic results while reducing the potential for antibiotic resistance.
2.Necrotising fasciitis and traditional medical therapy-- a dangerous liaison.
Yi-Jia LIM ; Fok-Chuan YONG ; Chin-Ho WONG ; Agnes B H TAN
Annals of the Academy of Medicine, Singapore 2006;35(4):270-273
INTRODUCTIONNecrotising fasciitis is a disease associated with high morbidity and mortality, and multi-focal necrotising fasciitis is uncommon. We present 2 cases of concurrent necrotising fasciitis of contralateral upper and lower limbs.
CLINICAL PICTUREBoth presented with pain, swelling, bruising or necrosis of the affected extremities. Traditional medical therapy was sought prior to their presentation.
TREATMENTAfter initial debridement, one patient subsequently underwent amputation of the contralateral forearm and leg. The other underwent a forearm amputation, but refused a below-knee amputation.
OUTCOMEThe first patient survived, while the second died.
CONCLUSIONTraditional medical therapy can cause bacterial inoculation, leading to necrotising fasciitis, and also leads to delay in appropriate treatment. Radical surgery is needed to optimise patient survival.
Aged ; Amputation ; Debridement ; Fasciitis, Necrotizing ; diagnosis ; drug therapy ; surgery ; Fatal Outcome ; Female ; Hand ; microbiology ; surgery ; Humans ; Leg ; microbiology ; surgery ; Male ; Medicine, East Asian Traditional ; Middle Aged ; Risk Factors
3.Neonatal and Paediatric Extracorporeal Membrane Oxygenation (ECMO) in a Single Asian Tertiary Centre.
Angela S H YEO ; Jin Ho CHONG ; Teng Hong TAN ; Agnes S B NG ; Victor Samuel RAJADURAI ; Yoke Hwee CHAN
Annals of the Academy of Medicine, Singapore 2014;43(7):355-361
INTRODUCTIONExtracorporeal membrane oxygenation (ECMO) is a cardiopulmonary bypass technique (CPB) which provides life-saving support in patients with refractory cardiorespiratory failure until cardiopulmonary recovery or organ replacement.
MATERIALS AND METHODSThis is a single centre retrospective study reporting the largest series of paediatric patients in Singapore who received ECMO support over an 11-year period from January 2002 to December 2012. The objective is to describe the characteristics of the patients and to report the survival to hospital discharge, complications during ECMO and other long-term complications.
RESULTSForty-eight patients received ECMO during the study period. ECMO was initiated for myocarditis in majority of the paediatric patients whereas postoperative low cardiac output state was the most common indication in the neonatal population. The overall survival rate to hospital discharge was 45.8%. Survival was highest in the neonates with respiratory failure (75%). Haematological and cardiac complications were most common during ECMO. Age group, gender, duration of ECMO, need for renal replacement therapy, acute neurological complications were not associated with mortality. Those needing inotropic support during ECMO had poorer survival while those with hypertension requiring vasodilator treatment had a higher survival rate. The survival rates for ECMO patients more than doubled from the initial 6 years of 23% to 54% in the last 5 years of the study period. Long-term complications encountered included neurological, respiratory and cardiac problems.
CONCLUSIONECMO is a life-saving modality for neonatal and paediatric patients with cardiopulmonary failure from diverse causes. Patients with persistent need for inotropes during ECMO had poorer outcome. Centre experience had an impact on ECMO outcome.
Adolescent ; Child ; Child, Preschool ; Extracorporeal Membrane Oxygenation ; adverse effects ; Female ; Heart Failure ; therapy ; Humans ; Infant ; Infant, Newborn ; Male ; Patient Discharge ; Respiratory Insufficiency ; mortality ; therapy ; Retrospective Studies ; Survival Rate ; Tertiary Care Centers ; Young Adult
4.Peritoneal dialysis for refractory heart failure from a congenitally corrected transposition of the great arteries who has not undergone definitive surgery: A case report
Sheryll Anne R. Manalili ; Agnes D. Mejia ; Ronaldo H. Estacio
Acta Medica Philippina 2023;57(4):57-62
Heart failure (HF) is a major cause of significant morbidity, mortality, and hospitalization worldwide including the
Philippines. Congenitally corrected transposition of the great arteries (C-TGA) occurs when the right atrium enters the morphological left ventricle which gives rise to the pulmonary artery and the left atrium communicates with the right ventricle which gives rise to the aorta. Heart failure can occur in C-TGA especially if associated with other heart defects. Ideal management is anatomic correction via surgery to prevent or address heart failure. Peritoneal dialysis has been used as a therapeutic intervention for patients with refractory heart failure and kidney injury with or without kidney failure due to its gentler fluid removal compared to conventional ultrafiltration resulting in less myocardial stunning and neurohormonal activation. We present the case of a patient with heart failure who started on peritoneal dialysis (PD) as an adjunct therapy for fluid management after failing to satisfactorily achieve volume control with diuretics.
The patient is a 56-year-old man with C-TGA admitted for decompensated heart failure. He was initially treated
with intravenous diuretics on the first admission but was readmitted after 3 months for decompensation this time with borderline low blood pressure making diuresis difficult. The patient was given loop diuretics, tolvaptan, and angiotensin receptor neprilysin inhibitor (ARNI) but still with decreasing trends in urine output and inadequate symptom control. PD was initiated before discharge with subsequent improvement in heart failure symptoms. The patient was on regular follow-up for PD maintenance and titration of heart failure medication.
In this case report, we have shown how PD can be an effective adjunct to guideline-directed medical therapy in
patients with severely symptomatic heart failure who have an unstable hemodynamic status and for which volume management cannot be satisfactorily achieved with diuretics.
peritoneal dialysis
;
heart failure
;
congenital heart disease
;
congenitally corrected transposition of the great arteries
;
diuresis
;
ultrafiltration
5.Placental mosaicism in multiple gestation: Complete hydatidiform mole with coexisting twin fetus.
Agnes L. Soriano-Estrella ; Victoria May H. Velasco-Redondo
Acta Medica Philippina 2024;58(11):81-89
Hydatidiform mole coexistent with a live fetus (CMCF) is a rare entity occurring in 1:20,000 to 1:100,000 pregnancies. Three mechanisms of this type are possible: (1) a singleton pregnancy consisting of partial mole with a triploid fetus, (2) a twin gestation consisting of an androgenic complete hydatidiform mole with a biparental diploid fetus, and (3) a twin gestation consisting of a biparental diploid fetus with a normal placenta and a partial hydatidiform mole (PHM) with a triploid fetus. The abnormal triploid fetus in a partial mole tends to die in the first trimester while the fetus coexisting with a complete or partial mole in the dizygotic twin pregnancy has a chance to survive. Early detection and diagnosis of a molar gestation with a viable fetus is needed to allow medical interventions, if available. Three cases of complete mole with a twin fetus (CMTF) that were diagnosed in the prenatal period by ultrasonography will be presented. This report will also discuss the indications for continuing the pregnancy, and review the literature on the recommended prenatal care, intrapartum management, and postpartum surveillance. This report aims to encourage others to document cases of CMTF in order to arrive at a consensus regarding its optimal management.
Hydatidiform Mole
;
Pregnancy, Twin
6.Convalescent plasma as adjunctive therapy for hospitalized patients with COVID-19:The Co-CLARITY Trial
Deonne Thaddeus V. Gauiran ; Teresita E. Dumagay ; Mark Angelo C. Ang ; Cecile C. Dungog ; Fresthel Monica M. Climacosa ; Sandy Chiong Maganito ; Rachelle N. Alfonso ; Anne Kristine H. Quero ; Josephine Anne C. Lucero ; Carlo Francisco N. Cortez ; Agnes Lorrainne M. Evasan ; Ruby Anne Natividad King ; Francisco M. Heralde III ; Lynn B. Bonifacio ; German J. Castillo, Jr. ; Ivy Mae S. Escasa ; Maria Clariza M. Santos ; Anna Flor G. Malundo ; Alric V. Mondragon ; Saubel Ezreal A. Salamat ; Januario D. Veloso ; Jose M. Carnate, Jr. ; Pedrito Y. Tagayuna ; Jodor A. Lim ; Marissa M. Alejandria ; Ma. Angelina L. Mirasol
Acta Medica Philippina 2024;58(2):5-15
Background and Objective:
Convalescent plasma therapy (CPT) may reduce the risk of disease progression among patients with COVID-19. This study was undertaken to evaluate the efficacy and safety of CPT in preventing ICU admission among hospitalized COVID-19 patients.
Methods:
In this open-label randomized controlled trial, we randomly assigned hospitalized adult patients with
COVID-19 in a 1:1 ratio to receive convalescent plasma as an adjunct to standard of care or standard of care alone. The primary endpoint was ICU admission within first 28 days of enrolment. Primary safety endpoints include rapid deterioration of respiratory or clinical status within four hours of convalescent plasma transfusion and cumulative incidence of serious adverse events during the study period including transfusion-related acute lung injury (TRALI), transfusion-associated circulatory overload (TACO), severe allergic reactions, and transfusion-related infections.
Results:
A total of 22 patients were assigned to receive convalescent plasma as an adjunct to standard of care and 22 to receive standard of care alone. The median time from onset of COVID-19 symptoms to study enrolment was eight days (IQR, 4 to 10). Two patients (9.1%) in the CPT group and one patient (4.5%) in the control group were admitted to the ICU. The primary outcome measure, ICU admission, was not different between the two groups (q-value >0.9). No patient who received convalescent plasma had rapid deterioration of respiratory/clinical status within four hours of transfusion and none developed TRALI, TACO, anaphylaxis, severe allergic reactions, or transfusion-related infections. There was also no significant difference in the secondary outcomes of 28-day mortality (two patients in the CPT group and none in the control group, q-value >0.90), dialysis-free days, vasopressor-free days, and ICU-free days.
Conclusions
Among hospitalized COVID-19 patients, no significant differences were observed in the need for
ICU admission between patients given CPT as adjunct to standard of care and those who received standard of
care alone. Interpretation is limited by early termination of the trial which may have been underpowered to
detect a clinically important difference.
COVID-19
;
COVID-19 Serotherapy